Telcon RF Pharmaceutical (XKRX:200230) Ending Cash Position : ₩0 Mil (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Telcon RF Pharmaceutical Ending Cash Position?

Telcon RF Pharmaceutical's Ending Cash Position for the quarter that ended in Mar. 2025 was ₩0 Mil.

Telcon RF Pharmaceutical's quarterly Ending Cash Position declined from Sep. 2024 (₩6,448 Mil) to Dec. 2024 (₩3,306 Mil) and declined from Dec. 2024 (₩3,306 Mil) to Mar. 2025 (₩0 Mil).

Telcon RF Pharmaceutical's annual Ending Cash Position declined from Dec. 2022 (₩9,734 Mil) to Dec. 2023 (₩8,519 Mil) and declined from Dec. 2023 (₩8,519 Mil) to Dec. 2024 (₩3,306 Mil).

Telcon RF Pharmaceutical Ending Cash Position Historical Data

The historical data trend for Telcon RF Pharmaceutical's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telcon RF Pharmaceutical Ending Cash Position Chart

Telcon RF Pharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

24,541.81

23,195.46

9,733.53

8,519.04

3,305.80

Telcon RF Pharmaceutical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															9,348.38	5,707.16	6,448.01	3,305.80	-

Telcon RF Pharmaceutical Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Telcon RF Pharmaceutical's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	8519.044	+	-5213.24
	=	3,306

Telcon RF Pharmaceutical's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0

Telcon RF Pharmaceutical Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Telcon RF Pharmaceutical's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Telcon RF Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Telcon RF Pharmaceutical Inc (XKRX:200230) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

684, Dongtangiheung-ro, Giheung-gu, Gyeonggi-do, Yongin-si, KOR, 17102

Website

http://www.telcon.co.kr

Telcon RF Pharmaceutical Inc manufactures wireless communication equipment. It develops connectors for input and output ports, board-to-board, cable assembly, and board-to-mount used in wireless communication equipment. The company also supplies RF coaxial connectors. The company operates in the RF Division and Pharmaceuticals & Biotechnology segments. The majority of its revenue is generated from Pharmaceuticals & Biotechnology, which produces and sells liquids, tablets, pills, capsules, etc.

Telcon RF Pharmaceutical Headlines

No Headlines